MedTrace Logo

AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease

NCT07721454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2026-07-23

No results posted yet for this study

Summary

The research project studies the possibility of using an artificial intelligence-based system in patients with advanced chronic liver disease (liver cirrhosis) to record variations in a patient's health status, with the aim of early identification of clinical improvement or deterioration. The system is based on the collection and processing of various clinical parameters through an Apple Watch. The study aims to evaluate whether the data generated by this system correlate with patients' clinical evolution and whether its use may ultimately contribute to improved care management and quality of life.

Conditions

  • Advance Chronic Liver Disease (ACLD)

Interventions

DEVICE

Apple Watch

Apple Watch has been used to specifically monitor patients with liver cirrhosis, who worn it for the period specified by the study

Sponsors & Collaborators

  • Antonio Galante

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-29
Primary Completion
2024-01-17
Completion
2024-01-17

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07721454 on ClinicalTrials.gov